Abstract
Reply: Faecal tumour pyruvate kinase M2: not a good marker for detection of colorectal adenomas
Highlights
(2) The calculations of Shastri and Stein regarding the number of screening colonoscopies performed in the gastroenterological practices are strongly misleading for several reasons
We thank Shastri and Stein for their interest in our work and we appreciate the opportunity to clarify the issues raised by these authors: (1) As described in the MATERIALS AND METHODS section, the study includes participants of screening colonoscopy
Study participants who are covered by the statutory health care system are typically aged 55 years or above corresponding to the age at which screening colonoscopy is offered by this health care modality
Summary
(2) The calculations of Shastri and Stein regarding the number of screening colonoscopies performed in the gastroenterological practices are strongly misleading for several reasons. Reply: Faecal tumour pyruvate kinase M2: not a good marker for detection of colorectal adenomas U Haug*,1, S Hundt1 and H Brenner1 1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Bergheimer Street 20, Heidelberg 69115, Germany
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
